{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:52:53Z","timestamp":1793641973121,"version":"4.5.1"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pharmthera.2020.107667","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T12:04:19Z","timestamp":1598357059000},"page":"107667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences"],"prefix":"10.1016","volume":"217","author":[{"given":"Hubertus","family":"Himmerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107667_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/nu9030225","article-title":"Micronutrient status in 153 patients with anorexia nervosa","volume":"9","author":"Achamrah","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/sltb.12477","article-title":"Predictors of suicide attempts in individuals with eating disorders","volume":"49","author":"Ahn","year":"2019","journal-title":"Suicide & Life-Threatening Behavior"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/Topiramate in severely obese adults: A randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0020","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-017-0796-4","article-title":"Treating eating disorders at higher levels of care: Overview and challenges","volume":"19","author":"Anderson","year":"2017","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","article-title":"Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial","volume":"47","author":"Andries","year":"2014","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0035","author":"ANZCTR"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0040","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/13543784.2019.1692813","article-title":"Investigational drugs for the treatment of binge eating disorder (BED): An update","volume":"28","author":"Appolinario","year":"2019","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/ndt\/14.4.957","article-title":"Anorexia nervosa: An important cause of chronic tubulointerstitial nephropathy","volume":"14","author":"Arimura","year":"1999","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0050","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and Topiramate versus phentermine\/Topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","article-title":"Olanzapine versus placebo in adult outpatients with anorexia nervosa: A randomized clinical trial","volume":"176","author":"Attia","year":"2019","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1461145710001434","article-title":"Evidence-based pharmacological treatment of generalized anxiety disorder","volume":"14","author":"Baldwin","year":"2011","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/eat.10235","article-title":"Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa","volume":"35","author":"Barbarich","year":"2004","journal-title":"International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1461145711000800","article-title":"Evidence-based pharmacotherapy of panic disorder: An update","volume":"15","author":"Batelaan","year":"2012","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/13651501.2017.1306082","article-title":"Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines","volume":"21","author":"Bauer","year":"2017","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.chc.2012.05.001","article-title":"Developmental epidemiology of anxiety disorders","volume":"21","author":"Beesdo-Baum","year":"2012","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0090","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1572-0241.2004.30246.x","article-title":"Gastric emptying in patients with restricting and binge\/purging subtypes of anorexia nervosa","volume":"99","author":"Benini","year":"2004","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0095","series-title":"Kompendium der Psychiatrischen Pharmakotherapie","author":"Benkert","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.nut.2006.06.004","article-title":"Vitamins and trace elements: Practical aspects of supplementation","volume":"22","author":"Berger","year":"2006","journal-title":"Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0105","first-page":"197","article-title":"Idiopathic edema and eating disorders: Evidence for an association","volume":"14","author":"Bihun","year":"1993","journal-title":"Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1098-108X(199404)15:3<251::AID-EAT2260150308>3.0.CO;2-#","article-title":"Controlled trial of zinc supplementation in anorexia nervosa","volume":"15","author":"Birmingham","year":"1994","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0115","series-title":"Medical management of eating disorders","author":"Birmingham","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/jcm8020278","article-title":"Medication in AN: A multidisciplinary overview of meta-analyses and systematic reviews","volume":"8","author":"Blanchet","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/tpj.2013.12","article-title":"Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder","volume":"14","author":"Brandl","year":"2014","journal-title":"Pharmacogenomics Journal"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/cap.2017.0133","article-title":"Adjunctive use of olanzapine in the treatment of avoidant restrictive food intake disorder in children and adolescents in an eating disorders program","volume":"27","author":"Brewerton","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0135","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11126-011-9192-0","article-title":"Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: Retrospective cohort study","volume":"83","author":"Calandra","year":"2012","journal-title":"The Psychiatric Quarterly"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107667_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/jpm9020022","article-title":"Pharmacogenetic tests in reducing accesses to emergency services and days of hospitalization in bipolar disorder: A 2-year Mirror analysis","volume":"9","author":"Callegari","year":"2019","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/2194-7511-1-25","article-title":"Occurrence of bipolar spectrum disorder and comorbidities in women with eating disorders","volume":"1","author":"Campos","year":"2013","journal-title":"International Journal of Bipolar Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0155","article-title":"To glance on psychiatric comorbidity in adolescent with anorexia nervosa","author":"Catone","year":"2019","journal-title":"Minerva Pediatrica"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2018.12.009","article-title":"Stress hormones and eating disorders","volume":"497","author":"Chami","year":"2019","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0165","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4065\/75.10.1015","article-title":"Anorectal dysfunction in constipated women with anorexia nervosa","volume":"75","author":"Chiarioni","year":"2000","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0170","first-page":"195","article-title":"Sleep disturbances in eating disorders: A review","volume":"162","author":"Cinosi","year":"2011","journal-title":"La Clinica Terapeutica"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0175","series-title":"Effect of dasotraline on body weight in patients with binge-eating disorder","author":"Citrome","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/10640260903585540","article-title":"Interpreting the complete blood count in anorexia nervosa","volume":"18","author":"Cleary","year":"2010","journal-title":"Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.phrs.2017.10.003","article-title":"Treatment of hypertension: The ESH\/ESC guidelines recommendations","volume":"128","author":"Cuspidi","year":"2018","journal-title":"Pharmacological Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107667_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070829","article-title":"Obesity with comorbid eating disorders: Associated health risks and treatment approaches","volume":"10","author":"Da Luz","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0195","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jpsychires.2018.06.002","article-title":"A meta-analysis of cytokine concentrations in eating disorders","volume":"103","author":"Dalton","year":"2018","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0200","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3390\/nu10111573","article-title":"Inflammatory markers in anorexia nervosa: An exploratory study","volume":"10","author":"Dalton","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbi.2019.05.012","article-title":"A longitudinal analysis of cytokines in anorexia nervosa","volume":"85","author":"Dalton","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2018.10.006","article-title":"A systematic review of in vitro cytokine production in eating disorders","volume":"497","author":"Dalton","year":"2019","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0215","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejcn.2016.115","article-title":"Hematological complications in anorexia nervosa","volume":"70","author":"De Filippo","year":"2016","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s40337-017-0164-0","article-title":"Identifying fundamental criteria for eating disorder recovery: A systematic review and qualitative meta-analysis","volume":"5","author":"De Vos","year":"2017","journal-title":"Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal","volume":"28","author":"Dell\u2019Osso","year":"2012","journal-title":"European Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0230","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1381612822666151214104826","article-title":"Depression, serotonin and tryptophan","volume":"22","author":"Dell\u2019Osso","year":"2016","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0235","series-title":"Anorexia and Bulimia Nervosa","article-title":"Patients\u2019 and Carers\u2019 perspectives of psychopharmacological interventions targeting anorexia nervosa symptoms","author":"Dessain","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0240","first-page":"34","article-title":"QTc prolongation with antidepressants and antipsychotics","volume":"40","author":"Dietle","year":"2015","journal-title":"US Pharmacist"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0245","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000369978","article-title":"Second-generation antipsychotic drugs in anorexia nervosa: A meta-analysis of randomized controlled trials","volume":"84","author":"Dold","year":"2015","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/21662630.2014.978804","article-title":"Reclamation of power and self: A meta-synthesis exploring the process of recovery from anorexia nervosa","volume":"3","author":"Duncan","year":"2015","journal-title":"Advances in Eating Disorders: Theory, Research and Practice"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0255","first-page":"231","article-title":"Eating disorder symptoms improved by antireflux surgery: A case report with a six-year follow up","volume":"46","author":"Eraslan","year":"2009","journal-title":"The Israel Journal of Psychiatry and Related Sciences"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/eat.23155","article-title":"Common genetic architecture and environmental risk factors underpin the anxiety-disordered eating relationship: Findings from an adolescent twin cohort","volume":"53","author":"Fairweather-Schmidt","year":"2020","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0265","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0304-3959(98)00108-0","article-title":"Effect of ondansetron, a 5-HT3 receptor, on the dynamic association between bulimic behaviors and pain thresholds","volume":"77","author":"Faris","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0270","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0140-6736(99)09062-5","article-title":"Effect of decreasing afferent vagal activity with Ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial","volume":"355","author":"Faris","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0275","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1210\/jc.2013-4105","article-title":"Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa","volume":"99","author":"Fazeli","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0280","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eat.22704","article-title":"The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa","volume":"50","author":"Frank","year":"2017","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0285","first-page":"80","article-title":"Diagnosis and therapy of bulimia nervosa","volume":"152","author":"Franke","year":"2010","journal-title":"MMW Fortschritte der Medizin"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107667_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/nu9030281","article-title":"Sensory Neuronopathy revealing severe vitamin B12 deficiency in a patient with anorexia nervosa: An often-forgotten reversible cause","volume":"9","author":"Franques","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0295","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus Topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0300","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.2337\/dc14-0930","article-title":"Weight-loss therapy in type 2 diabetes: Effects of phentermine and topiramate extended release","volume":"37","author":"Garvey","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0305","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2015.05.014","article-title":"Strong relationship between vitamin D status and bone mineral density in anorexia nervosa","volume":"78","author":"Gatti","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0310","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/eat.22731","article-title":"Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa","volume":"50","author":"Giollo","year":"2017","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0315","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-4362.2000.00924.x","article-title":"Prevalence of cutaneous manifestations in 200 patients with eating disorders","volume":"39","author":"Glorio","year":"2000","journal-title":"International Journal of Dermatology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0320","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/oby.2005.208","article-title":"Effect of orlistat in obese patients with binge eating disorder","volume":"13","author":"Golay","year":"2005","journal-title":"Obesity Research"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0325","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/jc.2004-1659","article-title":"Alendronate for the treatment of osteopenia in anorexia nervosa","volume":"90","author":"Golden","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0335","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1871524911006030207","article-title":"The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders","volume":"10","author":"Graeff","year":"2010","journal-title":"Central Nervous System Agents in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0340","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2174\/1871530318666180531094508","article-title":"Medical complications in anorexia and bulimia nervosa","volume":"18","author":"Gravina","year":"2018","journal-title":"Endocrine, Metabolic & Immune Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0345","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopsych.2005.03.001","article-title":"Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial","volume":"57","author":"Grilo","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0350","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The world Federation of Societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007033338715","article-title":"Gastrointestinal disturbances in anorexia nervosa and bulimia nervosa","volume":"2","author":"Hadley","year":"2003","journal-title":"Current Drug Targets. CNS and Neurological Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0360","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/FBP.0b013e328357440d","article-title":"Serotonin neurotransmission in anorexia nervosa","volume":"23","author":"Haleem","year":"2012","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0365","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lfs.2017.04.015","article-title":"Improving therapeutics in anorexia nervosa with tryptophan","volume":"178","author":"Haleem","year":"2017","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107667_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040792","article-title":"Micronutrients deficiencies in 374 severely malnourished anorexia nervosa inpatients","volume":"11","author":"Hanachi","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0375","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archpsyc.1997.01830220099014","article-title":"Treatment of bulimia nervosa with ondansetron","volume":"54","author":"Hartman","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0380","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00115-017-0421-0","article-title":"Correct treatment of mood disorders with Lithium","volume":"88","author":"Haussmann","year":"2017","journal-title":"Nervenarzt"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in Neuropsychopharmacology: Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0390","series-title":"Kompendium der Psychiatrischen Pharmakotherapie","first-page":"818","article-title":"Medikamente zur Behandlung von Esst\u00f6rungen und Adipositas","author":"Himmerich","year":"2019"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0395","doi-asserted-by":"crossref","DOI":"10.1177\/2045125318814734","article-title":"Genetic risk factors for eating disorders: An update and insights into pathophysiology","volume":"9","author":"Himmerich","year":"2019","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0400","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/09540261.2019.1571995","article-title":"Facets of shared decision-making on drug treatment for adults with an eating disorder","volume":"31","author":"Himmerich","year":"2019","journal-title":"International Review of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0405","series-title":"NeuroPsychopharmacotherapy","article-title":"Mood stabilizers: Side effects, contraindications, and interactions","author":"Himmerich","year":"2020"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00406-018-0937-8","article-title":"Psychiatric comorbidity as a risk factor for mortality in people with anorexia nervosa","volume":"269","author":"Himmerich","year":"2019","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0415","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","article-title":"Weight gain and metabolic changes during treatment with antipsychotics and antidepressants","volume":"15","author":"Himmerich","year":"2015","journal-title":"Endocrine, Metabolic and Immune Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.pra.0000369969.87779.1c","article-title":"Laboratory parameters and appetite regulators in patients with anorexia nervosa","volume":"16","author":"Himmerich","year":"2010","journal-title":"Journal of Psychiatric Practice"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0425","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17512433.2018.1383895","article-title":"Psychopharmacological advances in eating disorders","volume":"11","author":"Himmerich","year":"2018","journal-title":"Expert Review in Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0430","first-page":"979","article-title":"Body weight and bone\/calcium metabolism. Bone and calcium metabolism in anorexia nervosa","volume":"28","author":"Hotta","year":"2018","journal-title":"Clinical Calcium"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0435","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/erv.2178","article-title":"Mortality and its predictors in severe bulimia nervosa patients","volume":"21","author":"Huas","year":"2013","journal-title":"European Eating Disorders Review"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0440","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1038\/s41467-019-13544-0","article-title":"Genetic correlations of psychiatric traits with body composition and glycemic traits are sex- and age-dependent","volume":"10","author":"H\u00fcbel","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0445","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.040","article-title":"The prevalence and correlates of eating disorders in the national comorbidity survey replication","volume":"61","author":"Hudson","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0450","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","article-title":"Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: A randomized clinical trial","volume":"74","author":"Hudson","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0455","author":"Johns Hopkins University"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0460","first-page":"11","article-title":"Paracetamol: Mechanism of action, applications and safety concern","volume":"71","author":"J\u00f3\u017awiak-Bebenista","year":"2015","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0465","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.physbeh.2007.11.037","article-title":"Neurobiology of anorexia and bulimia nervosa","volume":"94","author":"Kaye","year":"2008","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0470","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1176\/appi.ajp.161.12.2215","article-title":"Comorbidity of anxiety disorders with anorexia and bulimia nervosa","volume":"161","author":"Kaye","year":"2004","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0475","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214874","article-title":"Copper deficiency as a cause of neutropenia in a case of coeliac disease","volume":"2016","author":"Khera","year":"2016","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0480","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ajcn\/50.4.767","article-title":"Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: Influence of weight recovery","volume":"50","author":"Kiyohara","year":"1989","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0485","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/jdi.12759","article-title":"Safety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist Liraglutide with an Oral Antidiabetic drug in Japanese patients with type 2 diabetes: Post-hoc analysis of a randomized, 52-week, open-label, parallel-group trial","volume":"9","author":"Kiyosue","year":"2018","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0490","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.schres.2013.11.009","article-title":"Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature","volume":"152","author":"Kluge","year":"2014","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0495","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MOP.0b013e3283487591","article-title":"Refeeding in anorexia nervosa: Increased safety and efficiency through understanding the pathophysiology of protein calorie malnutrition","volume":"23","author":"Kohn","year":"2011","journal-title":"Current Opinion in Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0500","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/epi4.12089","article-title":"Young people with epilepsy have an increased risk of eating disorder and poor quality diet","volume":"3","author":"Kolstad","year":"2017","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0505","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.encep.2016.02.017","article-title":"Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants","volume":"43","author":"Lebl\u00e9","year":"2017","journal-title":"Encephale"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0510","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/00048679109077729","article-title":"Acne as a risk factor for anorexia nervosa in Chinese","volume":"25","author":"Lee","year":"1991","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0515","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02850170","article-title":"Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: A single-blind randomized controlled trial","volume":"23","author":"Leombruni","year":"2006","journal-title":"Advances in Therapy"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0520","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.2.6136.526","article-title":"Hypothalamo-pituitary-thyroid function in anorexia nervosa: Influence of weight gain","volume":"2","author":"Leslie","year":"1978","journal-title":"British Medical Journal"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0525","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4088\/JCP.14m09299","article-title":"D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: A pilot randomized controlled trial","volume":"76","author":"Levinson","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0530","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/eat.23188","article-title":"Understanding suicide risk and eating disorders in college student populations: Results from a National Study","volume":"53","author":"Lipson","year":"2020","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0535","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0540","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s13311-017-0535-x","article-title":"Emerging treatments in eating disorders","volume":"14","author":"Lutter","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0545","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.euroneuro.2017.09.007","article-title":"Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [11C]MADAM","volume":"27","author":"Majuri","year":"2017","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0550","doi-asserted-by":"crossref","first-page":"219","DOI":"10.12740\/PP\/65274","article-title":"Gastrointestinal complications and refeeding guidelines in patients with anorexia nervosa","volume":"51","author":"Malczyk","year":"2017","journal-title":"Psychiatria Polska"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0555","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1176\/appi.ajp.159.3.492-a","article-title":"Orlistat misuse in bulimia nervosa","volume":"159","author":"Malhotra","year":"2002","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0560","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2174\/1871530318666180213111637","article-title":"Anorexia nervosa and comorbid psychopathology","volume":"18","author":"Marucci","year":"2018","journal-title":"Endocrine, Metabolic & Immune Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0565","doi-asserted-by":"crossref","first-page":"127","DOI":"10.9740\/mhc.2018.05.127","article-title":"Role of antidepressants in the treatment of adults with anorexia nervosa","volume":"8","author":"Marvanova","year":"2018","journal-title":"The Mental Health Clinician"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0570","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/appi.ajp.2013.13081149","article-title":"Type 1 diabetes mellitus and mortality risk in patients with anorexia nervosa","volume":"171","author":"Masters","year":"2014","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059538","article-title":"Copper deficiency leads to Anemia, duodenal hypoxia, Upregulation of HIF-2\u03b1 and altered expression of Iron absorption genes in mice","volume":"8","author":"Matak","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0580","doi-asserted-by":"crossref","DOI":"10.1186\/s40337-019-0262-2","article-title":"Eating disorders, bipolar disorders and other mood disorders: Complex and under-researched relationships","volume":"7","author":"McAulay","year":"2019","journal-title":"Journal of Eating Disorders"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2020.107667_bb0585","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4088\/JCP.sh16003su1c.03","article-title":"Pharmacologic treatments for binge-eating disorder","volume":"78","author":"McElroy","year":"2017","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0590","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jad.2010.06.037","article-title":"Prevalence and correlates of eating disorders in 875 patients with bipolar disorder","volume":"128","author":"McElroy","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0595","first-page":"3","article-title":"Naltrexone\/bupropion combination therapy in overweight or obese patients with major depressive disorder: Results of a pilot study","volume":"15","author":"McElroy","year":"2013","journal-title":"The Primary Care Companion for CNS Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40263-018-0594-5","article-title":"Progress in developing pharmacologic agents to treat bulimia nervosa","volume":"33","author":"McElroy","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","article-title":"Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: A randomized clinical trial","volume":"72","author":"McElroy","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0610","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jad.2004.11.008","article-title":"Comorbidity of bipolar and eating disorders: Distinct or related disorders with shared dysregulations?","volume":"86","author":"McElroy","year":"2005","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0615","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1177\/1535370216648805","article-title":"Copper, iron, and selenium dietary deficiencies negatively impact skeletal integrity: A review","volume":"241","author":"Medeiros","year":"2016","journal-title":"Experimental Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0620","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMcp022813","article-title":"Bulimia Nervosa","volume":"349","author":"Mehler","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0625","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eat.20593","article-title":"Treatment of osteopenia and osteoporosis in anorexia nervosa. A systematic review of the literature","volume":"42","author":"Mehler","year":"2009","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0630","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/eat.20554","article-title":"High risk of osteoporosis in male patients with eating disorders","volume":"41","author":"Mehler","year":"2008","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0635","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2005-2818","article-title":"Determinants of skeletal loss and recovery in anorexia nervosa","volume":"91","author":"Miller","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0640","doi-asserted-by":"crossref","unstructured":"Misra, M. (2008). Long-term skeletal effects of eating disorders with onset in adolescence. Annals of the New York Academy of Sciences 1135, 212\u2013218.","DOI":"10.1196\/annals.1429.002"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0645","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/jbmr.447","article-title":"Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa","volume":"26","author":"Misra","year":"2011","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0650","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1185\/03007995.2013.820694","article-title":"Long-term treatment of anxiety disorders with pregabalin: A 1 year open-label study of safety and tolerability","volume":"29","author":"Montgomery","year":"2013","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0655","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/09540261.2013.845376","article-title":"Future roles of pharmacogenomic testing and biomarkers in psychiatry","volume":"25","author":"M\u00fcller","year":"2013","journal-title":"International Review of Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2020.107667_bb0660","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000139853","article-title":"Adverse effects of laxatives: Fact and fiction","volume":"47","author":"M\u00fcller-Lissner","year":"1993","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0665","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0670","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0675","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/S1092852918000135","article-title":"Dasotraline for the treatment of moderate to severe binge eating disorder in adults: Results from a randomized, double-blind, placebo-controlled study","volume":"23","author":"Navia","year":"2018","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0680","unstructured":"NICE (2014). Bipolar disorder: Assessment and management. Retrieved 08\/05\/2020 from https:\/\/www.nice.org.uk\/guidance\/cg185."},{"key":"10.1016\/j.pharmthera.2020.107667_bb0685","author":"NICE"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0690","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Nickel","year":"2005","journal-title":"International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0695","article-title":"Mortality in concurrent type 1 diabetes and anorexia nervosa","volume":"25","author":"Nielson","year":"2002","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.pharmthera.2020.107667_bb0700","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11892-017-0949-1","article-title":"Are eating disorders risk factors for type 2 diabetes? A systematic review and meta-analysis","volume":"22","author":"Nieto-Mart\u00ednez","year":"2017","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0705","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40519-016-0313-5","article-title":"Medical comorbidity of binge eating disorder","volume":"22","author":"Olguin","year":"2017","journal-title":"Eating and Weight Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0710","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00129804-200503000-00005","article-title":"Outpatient management of electrolyte imbalances associated with anorexia nervosa and bulimia nervosa","volume":"28","author":"Olson","year":"2005","journal-title":"Journal of Infusion Nursing"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0715","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S1516-44462011000500007","article-title":"A review of Latin American studies on binge eating disorder","volume":"33","author":"Palavras","year":"2011","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0720","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/7854_2017_22","article-title":"Oxytocin and interpersonal relationships","volume":"35","author":"Patin","year":"2018","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0725","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fphar.2020.00481","article-title":"Impact of TNF-\u03b1 inhibitors on body weight and BMI: A systematic review and meta-analysis","volume":"11","author":"Patsalos","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0730","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/eat.20506","article-title":"Low insulin-like growth factor I and leukopenia in anorexia nervosa","volume":"41","author":"Polli","year":"2008","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0735","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.eatbeh.2005.12.004","article-title":"Suicide and attempted suicide in eating disorders, obesity and weight\u2013image concern","volume":"7","author":"Pompili","year":"2006","journal-title":"Eating Behaviors"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0740","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0447.2010.01641.x","article-title":"A comprehensive meta-analysis of the risk of suicide in eating disorders","volume":"124","author":"Preti","year":"2011","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0745","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/da.22253","article-title":"Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment-resistant depression","volume":"31","author":"Price","year":"2014","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0750","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5001\/omj.2019.56","article-title":"Depression: Prevalence and associated risk factors in the United Arab Emirates","volume":"34","author":"Razzak","year":"2019","journal-title":"Oman Medical Journal"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0755","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.orcp.2015.03.005","article-title":"Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide\u2014A pilot study","volume":"9","author":"Robert","year":"2015","journal-title":"Obesity Research & Clinical Practice"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0760","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: Proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0765","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10620-017-4766-9","article-title":"Hepatic complications of anorexia nervosa","volume":"62","author":"Rosen","year":"2017","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0770","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00277-013-1672-x","article-title":"Hematological abnormalities in severe anorexia nervosa","volume":"92","author":"Sabel","year":"2013","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0775","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/eat.22481","article-title":"Cardiovascular complications of anorexia nervosa: A systematic review","volume":"49","author":"Sachs","year":"2016","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0780","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/eat.23192","article-title":"A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa","volume":"53","author":"Safer","year":"2020","journal-title":"The International Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0785","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12328-015-0611-x","article-title":"Gastrointestinal symptoms and disorders in patients with eating disorders","volume":"8","author":"Sato","year":"2015","journal-title":"Clinical Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0790","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2215-0366(16)00081-X","article-title":"Eating disorders: The big issue","volume":"3","author":"Schmidt","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0795","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.psc.2018.10.004","article-title":"The Microbiome and Eating Disorders","volume":"42","author":"Seitz","year":"2019","journal-title":"The Psychiatric clinics of North America"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0800","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.gastrohep.2013.11.001","article-title":"Update on gastroesophageal reflux disease","volume":"37","author":"Serra Pueyo","year":"2014","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0805","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4065\/mcp.2010.0070","article-title":"Identification and treatment of eating disorders in the primary care setting","volume":"85","author":"Sim","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0810","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17512433.2020.1698291","article-title":"Pharmacotherapy in obesity: A systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs","volume":"13","author":"Singh","year":"2020","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0815","doi-asserted-by":"crossref","DOI":"10.1186\/s40337-018-0205-3","article-title":"Treatment of children and adolescents with avoidant\/restrictive food intake disorder: A case series examining the feasibility of family therapy and adjunctive treatments","volume":"6","author":"Spettigue","year":"2018","journal-title":"Journal of Eating Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0820","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/gut.27.10.1120","article-title":"Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa","volume":"27","author":"Stacher","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0825","first-page":"48","article-title":"Roland Kuhn-100th birthday of an innovator of clinical psychopharmacology","volume":"45","author":"Steinberg","year":"2012","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0830","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.psc.2018.10.008","article-title":"Cognitive neuroscience of eating disorders","volume":"42","author":"Steinglass","year":"2019","journal-title":"The Psychiatric Clinics of North America"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0835","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40519-014-0138-z","article-title":"Renal complications in anorexia nervosa","volume":"19","author":"Stheneur","year":"2014","journal-title":"Eating and Weight Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0840","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jadohealth.2006.09.010","article-title":"Effects of oral contraceptive on bone mineral density in adolescent females with anorexia nervosa","volume":"39","author":"Strokosch","year":"2006","journal-title":"The Journal of Adolescent Health"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0845","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00128071-200506030-00003","article-title":"Dermatologic signs in patients with eating disorders","volume":"6","author":"Strumia","year":"2005","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0850","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF03354425","article-title":"Zinc supplementation in the treatment of anorexia nervosa","volume":"7","author":"Su","year":"2002","journal-title":"Eating and Weight Disorders"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0855","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/2212798411103030226","article-title":"Zinc as an appetite stimulator\u2014The possible role of zinc in the progression of diseases such as cachexia and sarcopenia","volume":"3","author":"Suzuki","year":"2011","journal-title":"Recent Patents on Food, Nutrition & Agriculture"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0860","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2337\/diacare.25.9.1571","article-title":"Classification of type 1 diabetic females with bulimia nervosa into subgroups according to purging behavior","volume":"25","author":"Takii","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0865","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8046479","article-title":"Hypovitaminosis D3, leukopenia, and human serotonin transporter polymorphism in anorexia nervosa and bulimia nervosa","volume":"2016","author":"Tasegian","year":"2016","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0870","author":"The Royal College of Psychiatrists"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0875","unstructured":"The Royal Colleges of Psychiatrists, Physicians and Pathologists. (2014). MARSIPAN: Management of Really Sick Patients with anorexia nervosa. 2nd edition. College report CR189. Retrieved 21\/12\/2019 from https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/better-mh-policy\/college-reports\/college-report-cr189.pdf?sfvrsn=6c2e7ada_2."},{"key":"10.1016\/j.pharmthera.2020.107667_bb0880","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-015-0652-3","article-title":"Interventions for the carers of patients with eating disorders","volume":"18","author":"Treasure","year":"2016","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0885","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ajem.2013.02.035","article-title":"ED management of patients with eating disorders","volume":"31","author":"Trent","year":"2013","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0890","first-page":"378","article-title":"Detection and importance of laxative use in adolescents with anorexia nervosa","volume":"39","author":"Turner","year":"2000","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0895","first-page":"107","article-title":"A three level-intervention to reduce PRN medication on a specialist eating disorders ward for adult female patients with anorexia nervosa","volume":"30","author":"Tyrrell-Bunge","year":"2018","journal-title":"Psychiatria Danubina"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0900","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.psychres.2015.09.008","article-title":"Psychiatric comorbidity in women and men with eating disorders results from a large clinical database","volume":"230","author":"Ulfvebrand","year":"2015","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0905","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1203\/00006450-199607000-00019","article-title":"Defective in vitro granulopoiesis in patients with anorexia nervosa","volume":"40","author":"Vaisman","year":"1996","journal-title":"Pediatric Research"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0910","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0915","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0920","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41588-019-0439-2","article-title":"Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa","volume":"51","author":"Watson","year":"2019","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0925","series-title":"Adipose tissue","article-title":"Physical and mental health consequences of obesity in women","author":"Weschenfelder","year":"2018"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0930","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjmed.2015.06.031","article-title":"Medical complications of anorexia nervosa and bulimia","volume":"129","author":"Westmoreland","year":"2016","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0935","doi-asserted-by":"crossref","first-page":"721","DOI":"10.12740\/PP\/35482","article-title":"Gastrointestinal motility disorders in patients with anorexia nervosa \u2013 A review of the literature","volume":"49","author":"Weterle-Smoli\u0144ska","year":"2015","journal-title":"Psychiatria Polska"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0940","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.0065-1591.2000.acp29-03.x","article-title":"Why do people with anxiety disorders become depressed? A prospective-longitudinal community study","volume":"102","author":"Wittchen","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0945","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cdtm.2015.11.004","article-title":"Esophageal ulcer induced by ibuprofen tablets","volume":"1","author":"Xu","year":"2016","journal-title":"Chronic Diseases and Translational Medicine"},{"key":"10.1016\/j.pharmthera.2020.107667_bb0950","article-title":"Multidisciplinary healthcare teams' challenges and strategies in supporting people with type 1 diabetes to recover from disordered eating","author":"Zaremba","year":"2019","journal-title":"Diabetic Medicine"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:27Z","timestamp":1759010907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820301972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":190,"alternative-id":["S0163725820301972"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107667","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107667"}}